BK Technologies - BKTI Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BK Technologies in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" BKTI shares.
View BKTI analyst ratings or view top-rated stocks.

BK Technologies saw a decrease in short interest in the month of March. As of March 15th, there was short interest totaling 4,400 shares, a decrease of 18.5% from the February 28th total of 5,400 shares. Based on an average daily trading volume, of 39,300 shares, the short-interest ratio is currently 0.1 days. Approximately 0.0% of the shares of the company are sold short.
View BK Technologies' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 10th 2023.
View our BKTI earnings forecast.

BK Technologies Co. (NYSEAMERICAN:BKTI) released its quarterly earnings results on Wednesday, August, 1st. The company reported $0.07 EPS for the quarter. The firm earned $13.66 million during the quarter. BK Technologies had a negative trailing twelve-month return on equity of 43.26% and a negative net margin of 22.83%.

BK Technologies declared a quarterly dividend on Friday, September 30th. Shareholders of record on Tuesday, October 25th will be given a dividend of $0.03 per share on Tuesday, November 8th. This represents a $0.12 dividend on an annualized basis and a yield of 4.21%. The ex-dividend date of this dividend is Monday, October 24th.
Read our dividend analysis for BKTI.

Dimensional US Small Cap Value ETF holds 1,033 shares of BKTI stock, representing 0.00% of its portfolio.

BK Technologies (NYSEAMERICAN:BKTI) pays an annual dividend of $0.09 per share and currently has a dividend yield of 2.83%.
Read our dividend analysis for BKTI.

BK Technologies's stock reverse split before market open on Monday, April 24th 2023. The 1-5 reverse split was announced on Monday, April 24th 2023. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, April 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other BK Technologies investors own include Main Street Capital (MAIN), NVIDIA (NVDA), Overstock.com (OSTK), Riot Platforms (RIOT), Boeing (BA), General Motors (GM), Pure Storage (PSTG), Enphase Energy (ENPH), QUALCOMM (QCOM) and Toll Brothers (TOL).

BK Technologies trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "BKTI."

BK Technologies' stock is owned by many different retail and institutional investors. Top institutional investors include AIGH Capital Management LLC (9.95%), Bard Associates Inc. (3.48%), Renaissance Technologies LLC (3.06%), Dimensional Fund Advisors LP (1.23%), Geode Capital Management LLC (0.49%) and Virtu Financial LLC (0.10%). Insiders that own company stock include Fundamental Global Gp, Llc, Global Investors Fundamental, John M Suzuki, Lloyd Roberts Sams, Robert Joseph Jackson and Scott A Malmanger.
View institutional ownership trends.

Shares of BKTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BKTI stock can currently be purchased for approximately $2.85.

BK Technologies (NYSEAMERICAN:BKTI) has a market capitalization of $48.45 million and generates $50.95 million in revenue each year. The company earns $-11,630,000.00 in net income (profit) each year or ($0.69) on an earnings per share basis.

The company employs 113 workers across the globe.

BK Technologies' mailing address is 7100 TECHNOLOGY DRIVE, WEST MELBOURNE FL, 32904. The official website for the company is www.bktechnologies.com. The company can be reached via phone at (321) 984-1414, via email at james@haydenir.com, or via fax at 321-984-0168.